(Q113890496)
Statements
A Phase 1 Randomized, Double Blinded, Placebo-Controlled Single Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of 611 in Adult Healthy Male and Female Volunteers (English)
0 references
September 2020
0 references
July 2021
0 references
40
0 references
18 year
0 references
55 year
0 references